Management of Macular Hemorrhage
Springer International Publishing (Verlag)
978-3-319-65875-9 (ISBN)
Sub- or preretinal hemorrhage involving the macula is a typical complication in a variety of ocular diseases, including age-related macular degeneration, arterial macroaneurysm, Valsalva retinopathy, and trauma. However, there is currently no consensus regarding the ideal treatment for macular hemorrhage.
The purpose of this book on macular hemorrhage is twofold: it aims both to impart valuable information on pathophysiology, risk factors, diagnostic aspects, and prognostic criteria under different conditions and to provide a systematic overview of therapeutic approaches that cover the most important situations a vitreoretinal surgeon might encounter when treating patients with this disorder. Case presentations, clinical photographs, and an extensive review of the literature supplement the important information on clinical decision making, surgical techniques, and typical pitfalls and invite the reader to explore the advantages and disadvantages of various approaches to the management of macular hemorrhage.Lars-Olof Hattenbach, M.D., F.E.B.O., is a Professor of Ophthalmology and the Director of the Department of Ophthalmology at Ludwigshafen Hospital, Germany. Dr. Hattenbach attended medical school at the Johann Wolfgang Goethe University, Frankfurt am Main and, as a final-year medical student, at the George Washington University Hospital, Washington D.C., U.S.A. After graduation, he passed the U.S. Foreign Medical Graduates Examination in the Medical Sciences, completed an internship in vascular medicine at the Johann Wolfgang Goethe University Hospital and participated in a cardiology residency program at the Charité, Berlin, before he specialized in ophthalmology at the university hospitals of Mainz and Frankfurt. He received his board certification in ophthalmology in 1999 and completed his postdoctoral degree in 2002. After being appointed senior attending physician of the Department of Vitreoretinal Surgery at the University Hospital of Frankfurt, he attained his position at Ludwigshafen in 2005.Dr. Hattenbach has served as the Principal Investigator for numerous clinical trials and has published extensively in the field, with almost 80 publications to his name in peer-reviewed journals. His main focus of clinical and scientific interest is in surgical and pharmacological treatments of posterior eye segment diseases. Dr. Hattenbach pioneered the use of recombinant tissue-plaminogen activator (rt-PA) to treat subretinal hemorrhage.
Types of Macular Hemorrhages and Clinical Appearance.- Macular Hemorrhage: Natural Course and Risk Factors.- Classification of Subretinal Hemorrhage.- The Pathophysiology of Subretinal Hemorrhage.- Anti-VEGF and Fibrinolytic Agents for the Management of Subretinal Hemorrhage.- Minimally Invasive Surgical Approaches to the Management of Macular Hemorrhages.- Surgical Treatment of Massive Subretinal Hemorrhage.- Macular Translocation in Submacular Hemorrhage Secondary to Age-Related Macular Degeneration.- Retinal Pigment Epithelium and Choroid Translocation in Massive Submacular Hemorrhage.-Surgical and Nonsurgical Treatment of Pre-Retinal Hemorrhages.- Management of Trauma Associated Macular Hemorrhages.
Erscheinungsdatum | 30.05.2018 |
---|---|
Zusatzinfo | IX, 96 p. 81 illus., 75 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Maße | 178 x 254 mm |
Gewicht | 394 g |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Augenheilkunde |
Schlagworte | Anti-VEGF Agents • Medicine • Medicine: general issues • Minimally Invasive Surgery • Ophthalmology • risk factors • Subretinal Hemorrhage • Sub RPE |
ISBN-10 | 3-319-65875-1 / 3319658751 |
ISBN-13 | 978-3-319-65875-9 / 9783319658759 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich